Cost-effectiveness analysis of infliximab, adalimumab,...

  • Main
  • 2019 / 05
  • Cost-effectiveness analysis of infliximab, adalimumab,...
European Journal of Hospital Pharmacy Science and Practice 2019 / 05

Cost-effectiveness analysis of infliximab, adalimumab, golimumab, vedolizumab and tofacitinib for moderate to severe ulcerative colitis in Spain

Trigo-Vicente, Cristina, Gimeno-Ballester, Vicente, López-Del Val, Alejandro
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
European Journal of Hospital Pharmacy
DOI:
10.1136/ejhpharm-2018-001833
Date:
May, 2019
File:
PDF, 658 KB
2019
Conversion to is in progress
Conversion to is failed